Hyperkinesia, Generalized
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.
|
21962519 |
2011 |
Language Delay
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Comparison of the clinical and cytogenetic findings of our patients with previously reported patients, supports that haploinsuffiency of CNTNAP2 can result in language delay and/or autism spectrum disorder.
|
21082657 |
2010 |
Language Delay
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
|
20157312 |
2011 |
Language Delay
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Recent studies of disorder reported that variants of the CNTNAP2 gene are associated both with language deficits in specific language impairment (SLI) and with language delays in autism.
|
21310003 |
2011 |
Language Development Disorders
|
0.310 |
Biomarker
|
group |
CTD_human |
CNTNAP2 variants affect early language development in the general population.
|
21310003 |
2011 |
Language Development Disorders
|
0.310 |
Biomarker
|
group |
CTD_human |
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
|
20157312 |
2011 |
Language Development Disorders
|
0.310 |
Biomarker
|
group |
CTD_human |
Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features.
|
21082657 |
2010 |
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
According to the location of significant signals, our study indicated that exon 13-15 of CNTNAP2 may play important roles in both schizophrenia and major depression in the Han Chinese population.
|
23123147 |
2013 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
We identified 13 common genes (ADARB2, CEACAM6, CNTNAP2, COL19A1, DEF4, DRAXIN, FCER2, HBG1, NCAPG2, PVRL2, SLC2A14, SNCA, and TCL1B) showing significant differential expression between G2019S-associated PD and asymptomatic carriers and also between idiopathic PD and controls but not between untreated and treated patients.
|
25475535 |
2015 |
PITT-HOPKINS SYNDROME
|
0.340 |
Biomarker
|
disease |
CTD_human |
We now identified homozygous and compound-heterozygous deletions and mutations via molecular karyotyping and mutational screening in CNTNAP2 and NRXN1 in four patients with severe mental retardation (MR) and variable features, such as autistic behavior, epilepsy, and breathing anomalies, phenotypically overlapping with Pitt-Hopkins syndrome.
|
19896112 |
2009 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Possible case of Pitt-Hopkins syndrome in sibs.
|
11568923 |
2001 |
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
Biomarker
|
disease |
CTD_human |
|
|
|
Pitt-Hopkins-Like Syndrome 1
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
|
16571880 |
2006 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
CTD_human |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Semantic-Pragmatic Disorder
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features.
|
21082657 |
2010 |
Semantic-Pragmatic Disorder
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
|
20157312 |
2011 |
Semantic-Pragmatic Disorder
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
CNTNAP2 variants affect early language development in the general population.
|
21310003 |
2011 |
Small cell carcinoma of lung
|
0.300 |
Biomarker
|
disease |
CTD_human |
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
|
22941189 |
2012 |
Speech Delay
|
0.310 |
Biomarker
|
disease |
CTD_human |
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
|
20157312 |
2011 |
Speech Delay
|
0.310 |
Biomarker
|
disease |
CTD_human |
CNTNAP2 variants affect early language development in the general population.
|
21310003 |
2011 |
Speech Delay
|
0.310 |
Biomarker
|
disease |
CTD_human |
Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features.
|
21082657 |
2010 |
Stammering
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case.
|
21108403 |
2010 |
Stuttering
|
0.320 |
Biomarker
|
phenotype |
CTD_human |
CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering.
|
21108403 |
2010 |
Stuttering, Acquired
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case.
|
21108403 |
2010 |
Stuttering, Adult
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case.
|
21108403 |
2010 |